Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by valentinemassonon Jul 23, 2020 11:45pm
137 Views
Post# 31312138

RE:RE:RE:RE:RE:RE:Bashers are a good sign

RE:RE:RE:RE:RE:RE:Bashers are a good sign
valentinemasson wrote:
ThunderAcDc wrote: I have two friends that bought shares in the $0.15 range few weeks ago...... please don't tell them that stupidity. They are really really mad and hope if one day, they will see their money back again!!!!

Can you name only ONE covid stock that made investors loose 2/3 of their investment?

Long term for what? Covid is NOW!!!!




 Attention: This is not a Covid stock. This is a company focused on Cancer treatment and more. They are utilizing their CLIA certified lab in Virginia producing results from their partners` tests. They do not own the test. Covid to SZLS is a stepping stone. With accurate results and the ability to maintain quantity and quality they are garnering attention. If you wish to compare, take MIR. 70% of their 685 million shares are owned by insiders , and have zero institutional investment. Sona: Flying high on hype , no FDA approval , nor have they officially applied for same. They are awaiting clinical trials to complete (COVID IS NOW!!) and yet the stock rises on hype. Many pot stocks did the same, and crashed hard. Not to say SONA will. Sona as well, has zero institutional investors.
SZLS has institutional investors.Generally speaking, big money doesn`t play the game to lose money.

 Given the history and track record here, it seems quite easy to project negativity. The market is awaiting results in Q2/Q3 to see if an uptick is imminent. Aristotle at this point is paramount to the long term success here. Covid testing is a tool , picks and shovels if you will , processing these FDA approved tests is no small deal. The funds generated frrom the up to 1000 tests per day will be used to finalize and promote Aristotle.

  If and when SZLS shines through, you may consider changing your moniker to "For those about to Rock" .

  Remember to wash your hands.

 VM


<< Previous
Bullboard Posts
Next >>